Q1 Earnings Estimate for Waters Issued By Leerink Partnrs

Waters Co. (NYSE:WAT - Free Report) - Equities research analysts at Leerink Partnrs lowered their Q1 2025 EPS estimates for Waters in a report released on Wednesday, February 12th. Leerink Partnrs analyst P. Souda now expects that the medical instruments supplier will post earnings of $2.21 per share for the quarter, down from their prior forecast of $2.45. The consensus estimate for Waters' current full-year earnings is $12.88 per share. Leerink Partnrs also issued estimates for Waters' Q1 2025 earnings at $2.21 EPS, Q4 2025 earnings at $4.42 EPS, Q4 2025 earnings at $4.42 EPS, FY2025 earnings at $12.84 EPS, FY2026 earnings at $14.05 EPS and FY2026 earnings at $14.05 EPS.

Waters (NYSE:WAT - Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share for the quarter, topping analysts' consensus estimates of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%.

WAT has been the subject of several other reports. Scotiabank upgraded Waters from a "sector perform" rating to a "sector outperform" rating and lifted their target price for the stock from $430.00 to $450.00 in a research report on Thursday, February 13th. UBS Group lifted their price objective on shares of Waters from $405.00 to $410.00 and gave the company a "neutral" rating in a report on Thursday, February 13th. Sanford C. Bernstein raised shares of Waters from a "market perform" rating to an "outperform" rating and set a $430.00 target price on the stock in a research report on Friday, January 10th. Barclays upgraded Waters from an "underweight" rating to an "equal weight" rating and boosted their price target for the company from $360.00 to $415.00 in a report on Monday, February 10th. Finally, StockNews.com upgraded Waters from a "hold" rating to a "buy" rating in a report on Monday. Ten investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Waters presently has a consensus rating of "Hold" and an average target price of $390.40.

Waters Trading Up 0.3 %

Shares of NYSE WAT traded up $1.01 during midday trading on Monday, hitting $377.30. The company's stock had a trading volume of 553,526 shares, compared to its average volume of 463,026. The business's 50 day moving average is $388.97 and its two-hundred day moving average is $365.18. Waters has a 12-month low of $279.24 and a 12-month high of $423.56. The company has a current ratio of 0.94, a quick ratio of 0.65 and a debt-to-equity ratio of 1.14. The firm has a market cap of $22.40 billion, a P/E ratio of 35.23, a price-to-earnings-growth ratio of 3.67 and a beta of 1.01.

Hedge Funds Weigh In On Waters

Large investors have recently made changes to their positions in the business. Advisory Alpha LLC increased its position in Waters by 2.6% during the 4th quarter. Advisory Alpha LLC now owns 1,065 shares of the medical instruments supplier's stock valued at $395,000 after buying an additional 27 shares in the last quarter. Summit Trail Advisors LLC increased its holdings in shares of Waters by 2.4% during the third quarter. Summit Trail Advisors LLC now owns 1,198 shares of the medical instruments supplier's stock valued at $431,000 after acquiring an additional 28 shares in the last quarter. Empowered Funds LLC raised its position in shares of Waters by 3.0% in the 4th quarter. Empowered Funds LLC now owns 966 shares of the medical instruments supplier's stock valued at $358,000 after purchasing an additional 28 shares during the last quarter. Deroy & Devereaux Private Investment Counsel Inc. boosted its stake in Waters by 0.3% in the 4th quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 9,610 shares of the medical instruments supplier's stock worth $3,565,000 after purchasing an additional 30 shares in the last quarter. Finally, OneDigital Investment Advisors LLC grew its position in Waters by 3.8% during the 3rd quarter. OneDigital Investment Advisors LLC now owns 851 shares of the medical instruments supplier's stock worth $306,000 after purchasing an additional 31 shares during the last quarter. 94.01% of the stock is owned by institutional investors and hedge funds.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.